首页> 美国卫生研究院文献>other >NOVEL CHARACTERIZATION OF bEnd.3 CELLS THAT EXPRESS LYMPHATIC VESSEL ENDOTHELIAL HYALURONAN RECEPTOR-1
【2h】

NOVEL CHARACTERIZATION OF bEnd.3 CELLS THAT EXPRESS LYMPHATIC VESSEL ENDOTHELIAL HYALURONAN RECEPTOR-1

机译:表达bend.3细胞的淋巴管内皮细胞透明质酸受体1的新颖表征。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Murine bEnd.3 endothelioma cell line has been widely used in vascular research and here we report the novel finding that bEnd.3 cells express lymphatic vessel endothelial hyaluronan receptor-1 (LYVE-1) and vascular endothelial growth factor receptor-3 (VEGFR-3). Moreover, these cells express progenitor cell markers of Sca-1 and CD133. Upon stimulation with tumor necrosis factor-alpha (TNF-α), the bEnd.3 cells demonstrate enhanced formation of capillary-type tubes, which express LYVE-1. As the bEnd.3 cell line is derived from murine endothelioma, we further examined human tissues of endothelioma and identified lymphatic vessels in the tumor samples which express both LYVE-1 and podoplanin. Moreover, a significantly higher number of lymphatic vessels were detected in the endothelioma samples compared with normal control. Taken together, this study not only redefines bEnd.3 cells for vascular research, but also indicates a broader category of human diseases that are associated with lymphatics, such as endothelioma.
机译:鼠bEnd.3内皮细胞瘤细胞已广泛用于血管研究,在这里我们报道了这一新发现,即bEnd.3细胞表达淋巴管内皮透明质酸受体1(LYVE-1)和血管内皮生长因子受体3(VEGFR- 3)。而且,这些细胞表达Sca-1和CD133的祖细胞标记。受肿瘤坏死因子-α(TNF-α)刺激后,bEnd.3细胞显示出表达LYVE-1的毛细血管的形成增强。由于bEnd.3细胞系来源于鼠内皮细胞瘤,我们进一步检查了人体内皮细胞组织,并在表达LYVE-1和Podoplanin的肿瘤样品中鉴定出淋巴管。而且,与正常对照相比,在内皮瘤样品中检测到明显更多的淋巴管。综上所述,这项研究不仅重新定义了bEnd.3细胞用于血管研究,而且还指出了与淋巴瘤相关的人类疾病的更广泛类别,例如内皮细胞瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号